在经济评估中包含不良事件的方法:改进建议
Salah Ghabri1, Dalia Dawoud2, Michael Drummond3
1Department of Medical Evaluation, French National Authority for Health (HAS), Saint-Denis La Plaine, France.
概括
将不良事件 (AE) 纳入卫生技术经济评估对于明智的医疗保健决策至关重要. 本研究确定了关键问题,并提出了在经济模型中处理AE的最佳实践建议.
科学领域:
- 卫生经济学 卫生经济学
- 药物经济学 药物经济学
- 卫生技术评估 卫生技术评估
背景情况:
- 有效的医疗保健决策需要将安全结果,特别是不良事件 (AE) 纳入卫生技术的经济评估中.
- 当前的经济评估经常面临挑战,需要充分纳入AE对成本和生活质量的影响.
研究的目的:
- 在将不良事件 (AE) 纳入医疗技术经济评估中确定关键问题.
- 在这些评估中探索前景,并为处理AE的最佳实践制定建议.
主要方法:
- 专注于将AE纳入经济评估中的方法论挑战.
- 研究了AE在决策模型中的纳入,AE术语,AE后果估计 (生活质量和成本),以及不确定性分析.
主要成果:
- 突出了决策模型整合,AE术语和量化AE对生活质量和成本的影响的问题.
- 证明需要更好的现实世界的安全数据和更好的方法来捕捉AE后果.
结论:
- 确定了将不良药物事件纳入经济评估中的关键方法问题.
- 提出了建议,以指导卫生技术评估机构和研究人员制定强有力的研究实践.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
126
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
126
Strategies for Assessing and Addressing Confounding
99
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
99
Hazard Ratio
118
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
118
Comparing the Survival Analysis of Two or More Groups
181
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
181
Bias in Epidemiological Studies
256
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
256
Assumptions of Survival Analysis
126
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
126


